Archive for September, 2008
COPD Drugs Associated with Increased Risk of Heart Attack and Stroke
Lawyers and Attorneys at our firm are investigating cases of heart attacks, stroke, and sudden cardiac death in users of Spriva and Atrovent.
A study released today concludes that individuals using inhaled anticholinergic agents, such as Spriva and Atrovent, are at an increased risk for heart attack, stroke, and sudden cardiac death. Specifically, use of [...]
Popularity: 36% [?]
23Sep2008 | PharmaWatchDog | 0 comments | Continued
Arthritis Drugs associated with Deadly Infections & Cancer
Lawyers and Attorneys working at our firm are investigating the association between Humira, Cimzia, Enbrel, and Remicade with deadly infections and cancer.
U.S. Food and Drug Administration announced that the manufacturers of Humira, Cimzia, Enbrel, and Remicade must strengthen the existing warnings, in the Warnings and Precaution sections of the drugs’ prescribing information and Medication Guides, on [...]
Popularity: 40% [?]
8Sep2008 | PharmaWatchDog | 0 comments | Continued
Byetta Associated with Necrotizing Pancreatitis
Lawyers and Attorneys working for our firm have been investigation claims that Byetta caused necrotizing pancreatitis since the FDA issued information for healthcare professionals in October 2007. Since then the FDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in patients taking Byetta. Byetta is a medicine given by subcutaneous injection to [...]
Popularity: 38% [?]
1Sep2008 | PharmaWatchDog | 1 comment | Continued
Recall of ED Supplement because of Dangerous Ingredient
Jack Distribution, LLC announced that they are conducting a voluntary nationwide recall of all lot numbers of the company’s supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. New lots of Rize 2 and Rose 4 her (not subject to this recall) will contain lot numbers beginning in “BL”.
Jack Distribution, LLC, is [...]
Popularity: 29% [?]
1Sep2008 | PharmaWatchDog | 0 comments | Continued
